IRD ▲ +0.5% - Opus Genetics, Inc. $IRD - Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences Opus Genetics rose 0.5% following an announcement that it will present clinical data for its OPGx-BEST1 program at upcoming investor and industry conferences. The data presentation, focusing on Cohort 1 results, represents a milestone in the company's ophthalmology pipeline that investors have been awaiting. 02-SEP-2026 07:01 AM ET